ZDA
MED icon

Zweig-DiMenna Associates’s Medifast MED Stock Holding History

Zweig-DiMenna Associates’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-112,400
Closed -$1.98M – 91
2024
Q4 		$1.98M Hold
112,400
– – 0.15% 78
2024
Q3 		$2.15M Hold
112,400
– – 0.22% 71
2024
Q2 		$2.45M Buy
+112,400
New +$3M 0.28% 63

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Zweig-DiMenna Associates's MED Position: Q1 2025 in Review

Zweig-DiMenna Associates sold out of Medifast (MED) in Q1 2025, closing a stake of 112,400 shares — an estimated $1.98M sold.

Zweig-DiMenna Associates first reported a position in MED in Q2 2024 and held it in 3 quarters. The position peaked at $2.45M in Q2 2024. 124 funds tracked by Wall St. Rank hold MED as of Q1 2025.

  • Zweig-DiMenna Associates reported no remaining Medifast position as of Q1 2025 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 112,400 Medifast shares in Q1 2025, an estimated $1.98M.
  • Zweig-DiMenna Associates first reported a position in Medifast in Q2 2024 and held it in 3 quarters.
  • Zweig-DiMenna Associates's Medifast position peaked at $2.45M in Q2 2024.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q1 2025.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2025, filed 7 May 2025.